These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 5823494)

  • 21. ACETYLCHOLINESTERASE: TRIMETHYLAMMONIUM-ION INHIBITION OF DEACETYLATION.
    KRUPKA RM
    Biochemistry; 1964 Nov; 3():1749-54. PubMed ID: 14235343
    [No Abstract]   [Full Text] [Related]  

  • 22. [Pyrilium, thiopyrilium and selenopyrilium salts--reversible cholinesterase inhibitors].
    Brestkin AP; Dmitrieva EN; Zhukovskiĭ IuG; Safonova AA; Sedavkina VA
    Dokl Akad Nauk SSSR; 1987; 293(6):1499-502. PubMed ID: 3608765
    [No Abstract]   [Full Text] [Related]  

  • 23. The inhibitory effect of Tris on the activity of cholinesterases.
    Pavlic M
    Biochim Biophys Acta; 1967 May; 139(1):133-7. PubMed ID: 6033464
    [No Abstract]   [Full Text] [Related]  

  • 24. [Kinetics of hydrolysis of the phenyl analog of acetylcholine under the action of cholinesterase from horse serum and acetylcholinesterase from bovine erythrocytes].
    Brestkin AP; Brik IL; Teplov NE
    Biokhimiia; 1968; 33(5):1059-68. PubMed ID: 5703735
    [No Abstract]   [Full Text] [Related]  

  • 25. Electrophysiological estimation of the actions of acetylcholinesterase inhibitors on acetylcholine receptor and cholinesterase in physically isolated Aplysia neurones.
    Oyama Y; Hori N; Evans ML; Allen CN; Carpenter DO
    Br J Pharmacol; 1989 Mar; 96(3):573-82. PubMed ID: 2720293
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Kinetic evidence of multiple reversible cholinesterases based on inhibition by organophosphates.
    Main AR
    J Biol Chem; 1969 Feb; 244(3):829-40. PubMed ID: 5769183
    [No Abstract]   [Full Text] [Related]  

  • 27. The properties of acetylcholinesterase modified by interaction with the alkylating agent N,N-dimethyl-2-phenylaziridinium ion.
    Purdie JE
    Biochim Biophys Acta; 1969 Jul; 185(1):122-33. PubMed ID: 5816009
    [No Abstract]   [Full Text] [Related]  

  • 28. [About mechanism of interaction of phosphororganic inhibitors with cholinesterases of different origin].
    Rozengart EV; Basova NE; Suvorov AA
    Zh Evol Biokhim Fiziol; 2002; 38(3):208-13. PubMed ID: 12325259
    [No Abstract]   [Full Text] [Related]  

  • 29. Mechanisms of cholinesterase inhibition by inorganic mercury.
    Frasco MF; Colletier JP; Weik M; Carvalho F; Guilhermino L; Stojan J; Fournier D
    FEBS J; 2007 Apr; 274(7):1849-61. PubMed ID: 17355286
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Base-catalyzed and cholinesterase-catalyzed hydrolysis of acetylcholine and optically active analogs.
    Schowen KB; Smissman EE; Stephen WF
    J Med Chem; 1975 Mar; 18(3):292-300. PubMed ID: 1169323
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effect of tetraalkylammonium ions on the thermal inactivation of cholinesterases].
    Grigor'eva GM
    Biokhimiia; 1966; 31(4):736-9. PubMed ID: 5999961
    [No Abstract]   [Full Text] [Related]  

  • 32. The kinetics of cholinesterases measured fluorometrically.
    Siegel GJ; Lehrer GM; Silides D
    J Histochem Cytochem; 1966 Jun; 14(6):473-8. PubMed ID: 5963519
    [No Abstract]   [Full Text] [Related]  

  • 33. MOLECULAR PROPERTIES OF CHOLINESTERASES.
    SVENSMARK O
    Acta Physiol Scand Suppl; 1965; ():SUPPL:245:1-74. PubMed ID: 14292694
    [No Abstract]   [Full Text] [Related]  

  • 34. Studies on 4-phenylpiperidine series. X. Some geometric isomers of quaternary piperidinium salts with anticholinesterase activity.
    Iorio MA; Michalek H; Chiavarelli S
    Mol Pharmacol; 1969 Nov; 5(6):580-3. PubMed ID: 5392914
    [No Abstract]   [Full Text] [Related]  

  • 35. Studies of catalysis by acetylcholinesterase. I. Fluorescent titration with a carbamoylating agent.
    Rosenberry TL; Bernhard SA
    Biochemistry; 1971 Oct; 10(22):4114-20. PubMed ID: 5168614
    [No Abstract]   [Full Text] [Related]  

  • 36. [Determination of the molar concentration of acetylcholinesterase based on phosphorylation by paraoxon or soman].
    Nenner M
    Biochim Biophys Acta; 1971 Aug; 242(2):371-80. PubMed ID: 5160151
    [No Abstract]   [Full Text] [Related]  

  • 37. [Estimation of the irreversible inhibition reaction rate constants and of the concentration of cholinesterase active sites under commensurable concentrations of enzyme and inhibitors].
    Brestkin AP; Maizel EB; Smirnov OL
    Biokhimiia; 1975; 40(3):521-5. PubMed ID: 1203370
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Kinetics of cholinesterase hydrolysis of the substrate in the irreversible inhibition of the enzyme].
    Zhukovskiĭ IuG
    Izv Akad Nauk SSSR Biol; 1984; (1):55-61. PubMed ID: 6707315
    [No Abstract]   [Full Text] [Related]  

  • 39. A new method to characterize the kinetics of cholinesterases inhibited by carbamates.
    Xiao Q; Zhou H; Wei H; Du H; Tan W; Zhan Y; Pistolozzi M
    J Pharm Biomed Anal; 2017 Sep; 144():175-182. PubMed ID: 28483282
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dealkylation studies on inhibited acetylcholinesterase.
    Coult DB; Marsh DJ; Read G
    Biochem J; 1966 Mar; 98(3):869-73. PubMed ID: 5911531
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.